维普中文期刊产品整合服务
29篇 您的检索式:作者名="EGLESTON B"
    题名 作者 年代 出处 被引量
1Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer 显示文摘Burtness B Gibson M Egleston B 2009AnnOncol2009,20,7:1
2How patients with diatetes perceive their risk for major complications 显示文摘Mehzer D Egleston B 2000Eff Clin Pract2000,3,1:1
3Phase Ⅱ trial of docetaxel-irinotecan combination in advanced esophageal cancer显示文摘Burtness B Gibson M Egleston B 2009Annals of Oncology2009,20,7:1
4Phase 11 trial of docetaxel-irinotecan combination in advanced esopha-geal cancer显示文摘BURTNESS B GIBSON M EGLESTON B 2009Annals of Oncology2009,20,7:1
5Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors显示文摘Smaldone MC Kutikov A Egleston B 2012Urology2012,80,2:1
6Patterns of prostate cancer treat- ment by clinical stage and age显示文摘Meltzcr D Egleston B Abdalla i 2001Am J Public Health2001,91,1:1
7How patients with diabetes perceive their risk for major complications显示文摘Meltzer D Egleston B 2000Eff Clin Pract2000,3,1:1
8Tumor anatomic complexity is a predictor of malignancy but not tumor grade in patients with small renal masses(SRMs)显示文摘HASEEBUDDIN M UZZO R EGLESTON B 2015Eur Urol2015,14,2:1
9Baseline health perceptions, dysphagia ,and survival in patients with head and neck cancer显示文摘Lango MN Egleston B Fang C 2013Cancer2013,120,6:1
10Histopathological characteristics of localized renal cell carcinoma correlate with tumor size:a SEER analysis显示文摘Rothman J Egleston B Wong Y N 2009J Urol2009,181,:1
11Age, tumor size and rela- tive survival of patients with localized renal cell carcinoma : a sur- veillance, epidemiology and end results analysis 显示文摘Seoll B J Wong YN Egleston BL 2009J Urology2009,181,2:1
12Symp- tom distress in older adults following cancer surgery 显示文摘Van Cleave J H Egleston B L Ercolano E 2013Cancer Nuts2013,36,4:1
13llistopmhological char- acteristics of localized renal cell carcinoma correlate with tumor size : a SEER analysis显示文摘Rothman J Egleston B Wong YN 2009J Urology2009,181,:1
14How patients with diabetes perceive their risk for major complications显示文摘MELTZER D EGLESTON B 2000Eft Clin Pract2000,3,1:1
15Ana- tomic features of enhancing renal masses predict malig- nant and high-grade pathology: a preoperative nomo- gram using the RENAL nephrometry score 显示文摘Kutikov A Smaldone M C Egleston B L 2011Eur Urol2011,60,2:1
16Small renal masses progressing to metastases under active surveillance: asystematic review and poolsd analysis显示文摘Smaldone M C Kutikov A Egleston B L 2012Cancer2012,118,4:1
17Phase Ⅱ trial of docetaxel-irinotecan combination in advanced esophageal cancer显示文摘Burtness B Gibson M Egleston B 2009Ann Oncol2009,20,7:1
18Anatomic features of enhancing renal masses predict malignant and high-grade patholo- gy: apreoperative nomogram using the RENAL nephrometry score 显示文摘Kutikov A SmaldoneM Egleston B 2011Eur Urol2011,60,2:1
19A phase H trial of docetax- el-irinotecan combination in advanced esophageal cancer显示文摘Burtness B Gibson M Egleston B 2009Ann On- col2009,20,7:1
20Small renal masses progressing to metastases under active surveillance, a systematic review and pooled analysis 显示文摘Smaldone M C Kutikov A Egleston B L 2012Cancer2012,118,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费